Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/24/2003CA2459572A1 Composition comprising a lactobacillus pentosus strain and uses thereof
04/24/2003CA2458981A1 Combinations comprising cox-2 inhibitors and aspirin
04/23/2003EP1304338A1 Process for the preparation of Chondroitin sulfates from K4 Polysaccharide and obtained products
04/23/2003EP1304334A1 Novel antiandrogenic agent
04/23/2003EP1304330A2 Polymorph of 5-[4-[2-(N-Methyl-N-(2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dione maleic acid salt
04/23/2003EP1304327A2 Glutamine-thiazolidide and -pyrrolidide and their use as dipeptidylpeptidase IV inhibitors
04/23/2003EP1304323A1 Preventives or remedies for atopic dermatitis
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1304123A2 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
04/23/2003EP1304121A1 Body weight gain inhibitors
04/23/2003EP1304120A1 Use of oxaziridine derivatives and precursors for the treatment of dermatoses
04/23/2003EP1304111A2 Use of methylol-containing compounds for the treatment of breast cancer
04/23/2003EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/23/2003EP1304109A1 Liquid for oral administration comprising paroxetine
04/23/2003EP1304108A2 Anti-arrhythmic composition and methods of treatment
04/23/2003EP1304107A2 Use of oxazolidinines derivatives for treating psoriasis
04/23/2003EP1304106A1 FREEZE-DRIED PREPARATION OF N- o-(p-PIVALOYLOXYBENZENESULFONYLAMINO)BENZOYL]GLYCINE MONOSODIUM SALT TETRAHYDRATE AND PROCESS FOR PRODUCING THE SAME
04/23/2003EP1304105A2 Diffusional implantable delivery system
04/23/2003EP1304102A2 Combination of retinoids and cyclodextrins in cosmetic or dermatological O/W-emulsions
04/23/2003EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/23/2003EP1304046A1 Theobromine with an anti-carcinogenic activity
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1303632A2 Galactomannan oligosaccharides and methods for the production and use thereof
04/23/2003EP1303631A2 Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes
04/23/2003EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
04/23/2003EP1303608A2 Zinc finger domain recognition code and uses thereof
04/23/2003EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
04/23/2003EP1303599A2 Methylated nucleotide regulation of upa gene expression
04/23/2003EP1303596A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug
04/23/2003EP1303594A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b
04/23/2003EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it
04/23/2003EP1303541A1 Gel compositions containing metronidazole
04/23/2003EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use
04/23/2003EP1303535A2 Protein complex serving as a vehicle for orally administerable medicaments
04/23/2003EP1303528A1 Adenosine compound and pharmaceutical composition containing the same
04/23/2003EP1303527A1 Matrix metalloproteinase inhibitors
04/23/2003EP1303522A2 Biologically active macrolides, compositions, and uses thereof
04/23/2003EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives
04/23/2003EP1303520A1 Therapeutic compounds and methods
04/23/2003EP1303519A1 Tricyclic imidazopyridines
04/23/2003EP1303517A1 Indoloquinazolinones
04/23/2003EP1303516A1 Imidazolophthalazine derivatives as ligands for gaba a? receptors
04/23/2003EP1303515A2 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
04/23/2003EP1303514A1 Process for preparing azacycloalkanoylaminothiazoles
04/23/2003EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
04/23/2003EP1303512A1 Process for preparing arylacetylaminothiazoles
04/23/2003EP1303511A1 Oxazolidinone derivatives as antimicrobials
04/23/2003EP1303510A2 Cyclic oxyguanidine pyrazinones as protease inhibitors
04/23/2003EP1303509A1 Beta3 adrenergic agonists
04/23/2003EP1303508A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
04/23/2003EP1303507A1 Pyrimidine derivatives
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303503A2 Aniline derivatives
04/23/2003EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
04/23/2003EP1303500A1 Heterocyclic fluoroalkenyl thioethers (ii)
04/23/2003EP1303499A1 Tetrazole derivatives
04/23/2003EP1303496A1 Pyrimidine derivatives
04/23/2003EP1303495A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
04/23/2003EP1303491A1 Thrombin inhibitors comprising an aminoisoquinoline group
04/23/2003EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
04/23/2003EP1303488A1 Piperidine compounds for use as ccr-3 inhibitors
04/23/2003EP1303487A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP1303481A1 Phenylethylamine derivatives and their use in the treatment of melanoma
04/23/2003EP1303479A2 7-, 8- and 9-substituted tetracycline compounds
04/23/2003EP1303478A1 Process for the preparation of substituted octanoyl amides
04/23/2003EP1303477A2 1-amino-alkylcyclohexanes as 5-ht3- and neuronal nicotinicreceptor antagonists
04/23/2003EP1303312A2 Diagnosis of liver disease
04/23/2003EP1303308A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
04/23/2003EP1303307A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
04/23/2003EP1303306A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
04/23/2003EP1303305A2 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
04/23/2003EP1303301A2 Preventing airway mucus production by administration of egf-r antagonists
04/23/2003EP1303296A1 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof
04/23/2003EP1303293A2 Apo-2l receptor agonist and cpt-11 synergism
04/23/2003EP1303289A2 Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
04/23/2003EP1303282A1 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides
04/23/2003EP1303281A1 Methods of treatment
04/23/2003EP1303280A1 Enhanced brain function by gaba-ergic stimulation
04/23/2003EP1303279A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
04/23/2003EP1303278A1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
04/23/2003EP1303277A1 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
04/23/2003EP1303276A1 A bioavailable dosage form of loratadine
04/23/2003EP1303275A2 Paroxetine tablets and capsules
04/23/2003EP1303274A1 Method of promoting smoking cessation
04/23/2003EP1303273A1 New pharmaceutical composition and the process for its preparation
04/23/2003EP1303272A2 Benzothiazole derivatives
04/23/2003EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
04/23/2003EP1303270A1 Method for treating cryptorchidism
04/23/2003EP1303268A1 Highly purified simvastatin compositions
04/23/2003EP1303267A1 Dermal for amino laevulinic acid
04/23/2003EP1303266A1 Treatment of eating disorders using carboxyalkylethers
04/23/2003EP1303265A2 Use of cox-2 inhibitors for preventing immunodeficiency
04/23/2003EP1303264A1 Compositions and methods for treating cardiovascular disorders
04/23/2003EP1303263A2 Antibacterial method and composition wth phenolic compounds
04/23/2003EP1303262A2 Use of a spla2 inhibitor for the treatment of sepsis
04/23/2003EP1303261A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
1 ... 5492 5493 5494 5495 5496 5497 5498 5499 5500 5501 5502 5503 5504 5505 5506 5507 5508 5509 5510 5511 5512 ... 7860